Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Oncogene
    May 2017
  1. HAN AL, Veeneman BA, El-Sawy L, Day KC, et al
    Fibulin-3 promotes muscle-invasive bladder cancer.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    >> Share

    March 2017
  2. WAN W, Peng K, Li M, Qin L, et al
    Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1alpha.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    >> Share

    October 2016
  3. ZHANG H, Ye YL, Li MX, Ye SB, et al
    CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
    Oncogene. 2016 Oct 10. doi: 10.1038/onc.2016.
    >> Share

    March 2016
  4. CIAMPORCERO E, Shen H, Ramakrishnan S, Yu Ku S, et al
    YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
    Oncogene. 2016;35:1541-53.
    >> Share

    February 2016
  5. KING MA, Ganley IG, Flemington V
    Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells.
    Oncogene. 2016 Feb 8. doi: 10.1038/onc.2015.
    >> Share

    October 2015
  6. ZHAO D, Besser AH, Wander SA, Sun J, et al
    Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Oncogene. 2015;34:5447-59.
    >> Share

    June 2015
  7. PARK SJ, Shim JW, Park HS, Eum DY, et al
    MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B.
    Oncogene. 2015 Jun 1. doi: 10.1038/onc.2015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016